REDWOOD CITY, Calif. (AP) — REDWOOD CITY, Calif. (AP) — Corcept Therapeutics Inc. (CORT) on Thursday reported a loss of $31.2 million in its first quarter.
The Redwood City, California-based company said it had a loss of 30 cents per share.
The results met Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was also for a loss of 30 cents per share.
The drug developer posted revenue of $164.9 million in the period, which did not meet Street forecasts. Three analysts surveyed by Zacks expected $172.4 million.
Corcept expects full-year revenue in the range of $950 million to $1.05 billion.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CORT at https://www.zacks.com/ap/CORT
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
